Cargando…
Increased canonical NF-kappaB signaling specifically in macrophages is sufficient to limit tumor progression in syngeneic murine models of ovarian cancer
BACKGROUND: New treatment options for ovarian cancer are urgently required. Tumor-associated macrophages (TAMs) are an attractive target for therapy; repolarizing TAMs from M2 (pro-tumor) to M1 (anti-tumor) phenotypes represents an important therapeutic goal. We have previously shown that upregulate...
Autores principales: | Hoover, Alyssa A., Hufnagel, Demetra H., Harris, Whitney, Bullock, Kennady, Glass, Evan B., Liu, Esther, Barham, Whitney, Crispens, Marta A., Khabele, Dineo, Giorgio, Todd D., Wilson, Andrew J., Yull, Fiona E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542116/ https://www.ncbi.nlm.nih.gov/pubmed/33028251 http://dx.doi.org/10.1186/s12885-020-07450-8 |
Ejemplares similares
-
Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosis
por: Hufnagel, Demetra H., et al.
Publicado: (2020) -
Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer
por: Wilson, Andrew J., et al.
Publicado: (2015) -
Stimulating TAM-mediated anti-tumor immunity with mannose-decorated nanoparticles in ovarian cancer
por: Glass, Evan B., et al.
Publicado: (2022) -
Tracking NF-κB activity in tumor cells during ovarian cancer progression in a syngeneic mouse model
por: Wilson, Andrew J, et al.
Publicado: (2013) -
Inhibition of NF-kappaB activity in mammary epithelium increases tumor latency and decreases tumor burden
por: Connelly, Linda, et al.
Publicado: (2010)